InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.00%
)
US TECH 100
17,533.20
(
-0.45%
)
Dow Jones
38,884.26
(
0.00%
)
Brent Oil
81.96
(
-1.10%
)
Bitcoin
62,349.07
(
0.02%
)
Post# of 44784
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Melon4head

Send PM Follow Ignore
Followers 4
Posts 392
Boards Moderated 0
Alias Born 04/22/2015

Melon4head

Re: jp7204 post# 11907

Friday, 04/20/2018 10:51:21 AM

Friday, April 20, 2018 10:51:21 AM

Post# of 44784
I sort of remember. Chances are 50%- this individual was on the placebo.

I can't remember... Was there a "Crossover" design in the study? If so we may be hearing back from this individual in a positive way... If it was "Parallel"... The results should be the same...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!